Innovative Genomics Institute

IGI logoThe Innovative Genomics Institute is composed of diverse researchers with a powerful combined expertise. After the development of the CRISPR-Cas9 system for rewriting DNA, we saw the potential of applying this technology to solve some of humanity’s greatest problems. Our scientists conduct world-class research, driven by the real possibility to cure human disease, end hunger, and protect the environment.

In addition to our scientific efforts, the IGI is committed to advancing public understanding of genome engineering and providing resources for the broader community.

Director
Jennifer Doudna
Email
igi-info@berkeley.edu
Co-Director
Jonathan Weissman
Email
igi-info@berkeley.edu
Staff contact
Susan Jenkins
Email
sjenkins@berkeley.edu
Mailing address

Innovative Genomics Institute
2151 Berkeley Way
Berkeley, CA 94704



In News

February 4, 2021

More infectious COVID variant detected in Berkeley

A more transmissible variant of the coronavirus, first detected in the United Kingdom, has shown up in two UC Berkeley students, as the state announced at least 133 new cases of the variant statewide. The appearance of the new variant, which appears to be about 50% more infectious than earlier variants, reinforces the need to take very seriously public health precautions to prevent spread: wear a mask when around other people, keep at least six feet apart and wash your hands frequently.
July 1, 2020

UC Berkeley launches trial of saliva test for COVID-19

Scientists from the Innovative Genomics Institute (IGI), the same UC Berkeley group that rapidly popped up a state-of-the-art COVID-19 testing laboratory in March, are now trialing a quicker way to obtain patient samples: through saliva.